Navigation Links
Blindness can be stopped with drug for acne treatment

Stargardt's macular degeneration, also called juvenile macular degeneration, is an inherited disease which affects one in 10,000 people. This condition results from a defect in the ABCR gene, which is responsible for coding for a protein that removes all-trans-retinaldehyde, a vision byproduct, from retinal rods and cones. Rods and cones are supported by retinal-pigmented epithelium (RPE), a layer of cells near the retina. The accumulation of toxic pigments, or lipofuscin// results in the deterioration of the RPE leading to loss of rods and cones and subsequent central vision loss.

Researchers from the University of California, Los Angeles, have now found that Accutane, an acne treatment drug, stops the accumulation of lipofuscin in the eyes of mice with Stargardt's macular degeneration. Upon examination of the mice after two months of treatment with Accutane, the side effect of which includes night blindness, the researchers found no accumulation of toxins in the eyes. Gabriel Travis, M.D., suggested that the similarity of the mouse model with humans with Stargardt's makes it likely that Accutane will suppress lipofuscin from accumulating in Stargardt's patients.


'"/>




Page: 1

Related medicine news :

1. Smoking Linked to Blindness
2. Blindness may be genetic by nature
3. Enzyme Responsible For Congenital Blindness
4. Millions Of Diabetic And Glaucoma Patients Risk Blindness
5. Avastin, anti-Cancer Drug leads to Blindness and Other Complications
6. Genes That Were Responsible For The Cause Of Blindness Identified
7. Investigations Reveal That Infections Due To Contact lens Could Cause Blindness
8. Research into Blindness Cure Goes Digital
9. River Blindness Incidence Reduced With Effective Treatment
10. Blindness And Trachoma
11. Blindness cases in China on the rise
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
(Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
Breaking Medicine Technology: